Literature DB >> 5810970

Massive hepatic resection for the carcinoid syndrome.

R Zeegen, R Rothwell-Jackson, M Sandler.   

Abstract

Removal of the right lobe of the liver which was occupied largely by metastases, together with resection of ileal primary tumours, brought about complete remission of symptoms and signs in a 43-year-old man with a six-year history of the carcinoid syndrome. Investigations should be orientated toward surgery. When practicable, radical surgery of the type described here appears to offer the best hope of alleviating the distressing clinical features of the condition.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5810970      PMCID: PMC1552919          DOI: 10.1136/gut.10.8.617

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

1.  MALIGNANT CARCINOID SYNDROME TREATED BY RESECTION OF HEPATIC METASTASES.

Authors:  J J CHANDLER; J H FOSTER
Journal:  Am J Surg       Date:  1965-02       Impact factor: 2.565

2.  Right hepatic lobectomy. Technical problems and patient management.

Authors:  V L GUYNN; J T REYNOLDS; R J OVERSTREET
Journal:  Surg Clin North Am       Date:  1963-02       Impact factor: 2.741

3.  The serotonin syndrome in carcinoidosis.

Authors:  G B ELLIOTT; D A GRACE; H E GIBSON
Journal:  Can J Surg       Date:  1962-01       Impact factor: 2.089

4.  The malignant carcinoid syndrome: massive liver resection for symptomatic relief.

Authors:  H WILSON
Journal:  Am Surg       Date:  1959-08       Impact factor: 0.688

5.  Massive liver resection for control of severe vasomotor reactions secondary to malignant carcinoid.

Authors:  H WILSON; O D BUTTERICK
Journal:  Ann Surg       Date:  1959-05       Impact factor: 12.969

Review 6.  Pharmacologic and endocrine aspects of carcinoid syndrome.

Authors:  J A Oates; T C Butler
Journal:  Adv Pharmacol       Date:  1967

Review 7.  New understanding of the mechanism of the carcinoid flush.

Authors:  D T Mason; K L Melmon
Journal:  Ann Intern Med       Date:  1966-12       Impact factor: 25.391

8.  Hepatic lobectomy.

Authors:  M A Adson; R R Jones
Journal:  Arch Surg       Date:  1966-04

9.  [Clinical aspects and pathophysiology of carcinoid and carcinoid syndrome with special reference to the pharmacology of 5-hydroxytryptamine].

Authors:  H J KAEHLER; L HEILMEYER
Journal:  Ergeb Inn Med Kinderheilkd       Date:  1961

10.  Bronchial adenoma (carcinoid type) with solitary metastasis and associated functioning carcinoid syndrome.

Authors:  W R STANFORD; J E DAVIS; J U GUNTER; S G HOBART
Journal:  South Med J       Date:  1958-04       Impact factor: 0.954

View more
  6 in total

Review 1.  Progress report: the carcinoid syndrome.

Authors:  D G Grahame-Smith
Journal:  Gut       Date:  1970-02       Impact factor: 23.059

2.  Resection and embolization in the management of secondary hepatic tumors.

Authors:  L H Blumgart; D J Allison
Journal:  World J Surg       Date:  1982-01       Impact factor: 3.352

3.  Small bowel carcinoid tumors.

Authors:  H F Woods; N D Bax; J A Smith
Journal:  World J Surg       Date:  1985-12       Impact factor: 3.352

4.  Surgical approaches and drug treatment in the carcinoid syndrome.

Authors: 
Journal:  Br Med J       Date:  1978-06-17

5.  Long-term survival after surgical management of neuroendocrine hepatic metastases.

Authors:  Evan S Glazer; Jennifer F Tseng; Waddah Al-Refaie; Carmen C Solorzano; Ping Liu; Katherine A Willborn; Eddie K Abdalla; Jean-Nicolas Vauthey; Steven A Curley
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

6.  Use of arterial devascularization and cytotoxic drugs in 30 patients with the carcinoid syndrome.

Authors:  W M Melia; H B Nunnerley; P J Johnson; R Williams
Journal:  Br J Cancer       Date:  1982-09       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.